US Stock MarketDetailed Quotes

RLMD Relmada Therapeutics

Watchlist
  • 3.000
  • -0.030-0.99%
Trading Jun 20 13:02 ET
90.52MMarket Cap-958P/E (TTM)

Relmada Therapeutics Stock Analyst Ratings & Price Target

Analyst Rating

Updated: Jun 5, 2024

Based on 3 analysts giving stock ratings to Relmada Therapeutics in the past 3 months

Buy

  • Buy

    66.67%

  • Hold

    0.00%

  • Sell

    33.33%

Price Target

Updated: Jun 5, 2024

The average Relmada Therapeutics stock price target is 12.33 with a max estimate of 25.00 and a min estimate of 2.00

Review Relmada Therapeutics earnings estimates

Detailed RatingsDetailed RatingsDetailed Ratings

Detailed Ratings

Receive timely notifications of rating changes

View more detailed ratings of institutions and analysts

View rating details page for historical data

Download APP

Analyst Ratings Disclaimer

Analysis

Analyst Rating

Updated: Jun 5, 2024

Buy

  • Buy

    66.67%

  • Hold

    0.00%

  • Sell

    33.33%

Price Target

Updated: Jun 5, 2024

Heat List
US
Overall
Symbol
Latest Price
%Chg